ConductScience.org, home

Comparison · NCT04060667-fd595878

Intervention vs Control: Severe Maternal Outcome

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Intervention vs Control: Severe Maternal Outcome. Trial comparisons, record NCT04060667-fd595878. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04060667-fd595878

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.01610.01090.0237wilson
Risk in group 20.01530.01040.0224wilson
Risk difference, group 1 minus group 20.000855-0.007980.00987newcombe hybrid score
Risk ratio, group 1 over group 21.060.6091.83log
Odds ratio, group 1 over group 21.060.6051.85log
Number needed to treat, for one more participant with the outcome on Intervention than on Control1,170from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: control.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Intervention
Wireless physiologic monitoring: The intervention in this study is the use of a wireless monitor to perform physiologic monitoring of women undergoing emergency cesarean delivery for the first 24 hours after completion of the cesarean and send alerts to responding clinicians should vital signs fall out of a pre-specified range.
251,552OG000
Group 2ControlStandard of Care251,639OG001

Outcome

Type
PRIMARY
Title
Severe Maternal Outcome
Description
The primary effectiveness outcome was a composite measure of severe maternal morbidity (SMM) measured from enrollment until hospital discharge This composite measure is adapted from World Health Organization (WHO) near-miss morbidity criteria, as well as other severe maternal outcomes, including hysterectomy, cardiac arrest, prolonged unconsciousness, stroke, dialysis, intensive care admission, and death.
Time frame
From completion of the cesarean delivery until hospital discharge from the procedure, an average of 3 days
Population
Analysis was restricted to participants consenting for participation (intervention group) or with completed medical record review (control group)

Source ClinicalTrials.gov

Trial

Title
Wireless Physiologic Monitoring in Postpartum Women
NCT number
NCT04060667
Phases
NA
Conditions
Maternal Death During Childbirth, Pregnancy Complications
Interventions
Wireless physiologic monitoring
Lead sponsor
Massachusetts General Hospital
Results first posted
2025-09-09

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04060667-fd595878